The Legal 500
Webinars

Adapting to a new M&A landscape: security of supply, talent shortages, FDI regimes, and valuing deals, and how they are likely to drive M&A trends going forward.

24 May 2022, 4.00pm time

In Association With

← Back to Webinar homepage

Adapting to a new M&A landscape: security of supply, talent shortages, FDI regimes, and valuing deals, and how they are likely to drive M&A trends going forward.

Overview

While some of the key trends currently driving the M&A landscape were present throughout 2021 (eg, deglobalisation of supply chains; push for technology; thirst for talent), other such drivers were not altogether anticipated (eg, Russia’s invasion of Ukraine; the impact of inflation; global sanction regimes).  Join us for a webinar where we discuss these trends and how they will drive the M&A landscape during 2022.


Speakers

Robin Johnson

Partner, Eversheds Sutherland Robin is co-chair of Eversheds Sutherland’s cross-border M&A team and runs a team across 30 jurisdictions of over 100 lawyers. He is also sector chair of the diversified industrial sector group.

Mergermarket has placed Robin regularly in the top 10 of their Rainmaker leagues in the last eight years.

Legal Business in the UK recently voted Robin as one of the top ten M&A lawyers in the UK.

Antony Walsh

Partner, Eversheds Sutherland Antony is a partner in our corporate group and focuses on global M&A and treasury and structure projects for global major corporates, often for businesses in the industrials and/or technology sectors.

Antony is client relationship manager for global clients including: Brady Corp, TechnipFMC, Tenneco, Avery Dennison, General Motors (auto) and Eaton.

Hannah Kaye

Senior associate, Eversheds Sutherland Hannah is a senior associate in our corporate group. She has experience in international public and private M&A and reorganisations, acting for major corporates and private equity houses.

Hannah has recently returned from secondment at Smiths Group Plc where she worked on matters including the $3bn demerger of their medical division, the acquisition of Access Scientific and the acquisition of PathSensors by way of reverse merger.


In Association With